These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2288053)

  • 1. Nuclear DNA analysis: the relevance of ploidy, DNA heterogeneity and phases of the cell cycle in 329 patients with prostatic carcinoma. A study on a follow-up of eight years.
    al-Abadi H; Nagel R
    Urol Int; 1990; 45(6):350-5. PubMed ID: 2288053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of ploidy and DNA-heterogeneity in the primary diagnosis and monitoring of patients with locally advanced prostatic carcinoma.
    Nagel R; al Abadi H
    Scand J Urol Nephrol Suppl; 1991; 138():83-92. PubMed ID: 1785025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear DNA analysis: DNA heterogeneity in the monitoring of patients with locally advanced prostatic carcinoma.
    al-Abadi H; Nagel R
    Eur Urol; 1992; 22(4):303-10. PubMed ID: 1490508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
    al-Abadi H; Nagel R
    J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of DNA ploidy and proliferative activity in urothelial carcinoma of the renal pelvis and ureter. A study on a follow-up period of 6 years.
    Borgmann V; al-Abadi H; Nagel R
    Urol Int; 1991; 47(1):7-11. PubMed ID: 1871915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of locally advanced prostatic carcinoma with LHRH analogues: cytological, DNA-cytophotometrical, and clinical results.
    Borgmann V; al-Abadi H; Nagel R
    Am J Clin Oncol; 1988; 11 Suppl 1():S19-28. PubMed ID: 2968759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ploidy level and tumor progression in prostatic carcinoma.
    Zetterberg A; Forsslund G
    Acta Oncol; 1991; 30(2):193-9. PubMed ID: 2029404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near tetraploid prostate carcinoma. Methodologic and prognostic aspects.
    Forsslund G; Nilsson B; Zetterberg A
    Cancer; 1996 Oct; 78(8):1748-55. PubMed ID: 8859188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of nuclear DNA content in prostatic carcinoma.
    Forsslund G; Esposti PL; Nilsson B; Zetterberg A
    Cancer; 1992 Mar; 69(6):1432-9. PubMed ID: 1540880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of DNA ploidy in carcinoma of prostate.
    Dejter SW; Cunningham RE; Noguchi PD; Jones RV; Moul JW; McLeod DG; Lynch JH
    Urology; 1989 May; 33(5):361-6. PubMed ID: 2711553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic relevance of ploidy and proliferative activity of renal cell carcinoma.
    Al-Abadi H; Nagel R
    Eur Urol; 1988; 15(3-4):271-6. PubMed ID: 3215262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of modal deoxyribonucleic acid in low grade, low stage untreated prostate cancer.
    Adolfsson J; Rönström L; Hedlund PO; Löwhagen T; Carstensen J; Tribukait B
    J Urol; 1990 Dec; 144(6):1404-6; discussion 1406-7. PubMed ID: 2231935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of DNA ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the prostate: an image cytometric study.
    Baretton GB; Vogt T; Blasenbreu S; Löhrs U
    Hum Pathol; 1994 May; 25(5):506-13. PubMed ID: 8200645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic grade, DNA ploidy, and intraglandular tumor extent as indicators of tumor progression of clinical stage B prostatic carcinoma. A direct comparison.
    Humphrey PA; Walther PJ; Currin SM; Vollmer RT
    Am J Surg Pathol; 1991 Dec; 15(12):1165-70. PubMed ID: 1746683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-ploidy, G2M-fractions and prognosis of stages B and C prostate carcinoma.
    Müller JG; Demel S; Wirth MP; Manseck A; Frohmüller HG; Müller HA
    Virchows Arch; 1994; 424(6):647-51. PubMed ID: 8055159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transrectal fine needle aspiration biopsy of the prostate combining cytomorphologic, DNA ploidy status and cell cycle distribution studies.
    Paz-Bouza JI; Orfao A; Abad M; Ciudad J; Garcia MC; Lopez A; Bullon A
    Pathol Res Pract; 1994 Aug; 190(7):682-9. PubMed ID: 7528913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
    Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
    Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.